Position in BNTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,432,368
-$2,585,385 QoQ
Shares Held
79,875
-29.1% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#73
of 282 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Carmignac Gestion holds $277,738,773 across 9 Biotechnology names. BNTX ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
182,507 | $113,800,414 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
163,045 | $80,989,342 | |
| 3 | RPRX |
Royalty Pharma plc
|
630,700 | $35,363,349 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
321,000 | $25,452,090 | |
| 5 | TECH |
BIO-TECHNE Corp
|
124,530 | $8,798,044 | |
| 6 | BNTX |
BioNTech SE
This page
|
79,875 | $7,432,368 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
44,475 | $5,903,166 | |
| 8 | 95,603 | $0 |
All Filings in BNTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,432,368 | 79,875 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $10,017,753 | 112,711 | Shares | Sole | 2026-06-15 | |
| 2025-12-31 | $13,717,082 | 144,087 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,507,862 | 106,549 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $18,776,090 | 176,351 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $16,925,959 | 185,877 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,307,725 | 222,095 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $22,289,565 | 187,670 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,499,355 | 93,322 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||